Blueprint Medicines Corporation (BPMC)

Last Closing Price: 127.79 (2025-06-02)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Blueprint Medicines Corporation (BPMC) had Net Income of $-67.09M for the most recently reported fiscal year, ending 2024-12-31.

Figures for fiscal year ending 2024-12-31
Income Statement Financials
$508.82M
Net Income
$-67.09M
$20.16M
$488.66M
$720.87M
$-212.04M
$146.18M
$-65.86M
$-65.86M
$-67.09M
$-67.09M
$-67.09M
$-67.09M
$-212.04M
$-218.22M
62.86M
62.86M
$-1.07
$-1.07
Balance Sheet Financials
$742.68M
$36.59M
$437.13M
$1.18B
$260.80M
$343.05M
$620.35M
$881.15M
$298.67M
$298.67M
$298.67M
63.71M
Cash Flow Statement Financials
$-192.59M
$-47.50M
$273.11M
$81.52M
$113.64M
$32.12M
$108.91M
--
--
Fundamental Metrics & Ratios
2.85
--
--
0.53
1.30
96.04%
-41.67%
-41.67%
-42.89%
-12.94%
-13.19%
$-197.22M
--
--
--
0.43
1.48
6.56
55.67
-22.46%
-22.46%
-5.69%
-10.45%
$4.69
$-3.14
$-3.06